Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Lymphoma, Follicular × Pregabalin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 8 Pain 5 Breast Neoplasms 5 Neuralgia 4 Agnosia 4 Neoplasms 2 Head and Neck Neoplasms 2 Chronic Pain 2 Visceral Pain 1 Spinal Cord Neoplasms 1 Seizures 1 Pinealoma 1 Persistent Postoperative Pain 1 Pancreatic Neoplasms 1 Pain, Intractable 1 Oropharyngeal Neoplasms 1 Oligodendroglioma 1 Obesity 1 Neuroectodermal Tumors, Primitive 1 Myotoxicity 1 Meningioma 1 Medulloblastoma 1 Lymphoma, Follicular 1 Lymphoma 1 Liver Neoplasms 1 Leiomyoma 1 Inflammation 1 Hot Flashes 1 Gliosarcoma 1 Glioma 1

Interventions

Rituximab 249 Cyclophosphamide 210 fludarabine phosphate 90 Peripheral Blood Stem Cell Transplantation 89 Filgrastim 80 Etoposide 74 Lenalidomide 71 Radiotherapy 70 Vincristine 69 Prednisone 69 Doxorubicin 55 Bendamustine Hydrochloride 54 Mycophenolic Acid 53 Whole-Body Irradiation 51 Cyclosporine 50 fludarabine 46 Melphalan 46 Tacrolimus 41 Cytarabine 41 obinutuzumab 40 Busulfan 40 Methotrexate 38 Antilymphocyte Serum 34 Methylprednisolone 31 Carmustine 30 Bortezomib 30 Dexamethasone 28 sargramostim 27 ibritumomab tiuxetan 27 ibrutinib 25

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01789216 2021-02-03

PAIN

Major Extremity Trauma Research Consortium

Phase 3 Completed

Lymphoma, Follicular, Chronic Pain, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡